TABLE 4.
Chemokines CXCL10 and CXCL12 in relation to disease activity among the studied vitiligo patients (N=40)
| VARIABLE | ACTIVITY STATE ACCORDING TO VIDA SCORE (N = 40) | TEST* | P-VALUE | |
|---|---|---|---|---|
| Stable (n = 20) | Active (n = 20) | |||
| Serum level of CXCL10 (pg/mL) | ||||
| Mean ± SD | 200.0 ± 57.25 | 385.2 ± 58.44 | 0.000 | 0.000* (HS) |
| Median (range) | 215(91–275) | 382(283–496) | ||
| Serum level of CXCL12 (ng/mL) | ||||
| Mean ± SD | 2.66 ± 0.31 | 4.58 ± 0.61 | 1.000 | 0.000* (HS) |
| Median (range) | 2.63 (2.21–3.32) | 4.77(3.17–5.42) | ||
| Mean ± SD | 200.0 ± 57.25 | 385.2 ± 58.44 | 0.000 | 0.000* (HS) |
| Median (range) | 215(91–275) | 382(283–496) | ||
*Mann–Whitney U test
**NS: not significant (p > 0.05)